See product citations (3)
QUICK LINKS
STF 083010 inhibits IRE1 endonuclease activity specifically through endogenous XBP1 mRNA splicing. STF 083010 may act to induce cytotoxic and cytostatic effects in CD138+ multiple myeloma (MM) cells in vitro in addition to inhibiting bortezomib-induced XBP1 activity in myeloma xenografts in vivo. STF 083010 shows no effect against IRE1 kinase activity.
Ordering Information
Product Name | Catalog # | UNIT | Price | Qty | FAVORITES | |
STF 083010, 5 mg | sc-474562 | 5 mg | $127.00 | |||
STF 083010, 10 mg | sc-474562A | 10 mg | $180.00 | |||
STF 083010, 50 mg | sc-474562B | 50 mg | $400.00 | |||
STF 083010, 100 mg | sc-474562C | 100 mg | $700.00 | |||
STF 083010, 200 mg | sc-474562D | 200 mg | $1212.00 |